
Monoclonal Antibody Toxicity: Are Traditional Tests Enough?
Monoclonal antibody (mAb) therapeutics hold immense promise in treating various diseases, but ensuring their safety is paramount. This article examines whether traditional in vitro toxicity tests are sufficient for detecting off-target effects of mAbs, using Rituximab and Trastuzumab as case studies.